Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  OTC Bulletin Board - Other OTC  >  BioLargo, Inc.    BLGO

BIOLARGO, INC. (BLGO)
My previous session
Most popular
Delayed Quote. Delayed  - 01/17 10:27:54 am
0.234 USD   +4.93%
SummaryQuotesChartsNewsCompany 
News SummaryMost relevantAll newsOfficial PublicationsSector news

BIOLARGO, INC. : Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial Statements and Exhibits (form 8-K)

share with twitter share with LinkedIn share with facebook
share via e-mail
0
01/11/2019 | 04:45pm EST

Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

The discussion set forth in Item 1.01 is incorporated herein by reference.

--------------------------------------------------------------------------------

Item 9.01. Financial Statements and Exhibits.




(d)   Exhibits.




 Exhibit                 Exhibit Description                   Form    File Date
  Number

             Convertible Promissory Note issued to Vista
   10.1    Capital Investments LLC dated December 14,        Form 8-K  12/22/2017
           2017
             December 18, 2017, amendment to Promissory
   10.2    Note dated December 14, 2017 issued to Vista      Form 8-K  12/22/2017
           Capital Investments, LLC.
             September 2018 Amendment to Promissory Note
   10.3    dated December 14, 2017 issued to Vista Capital   Form 8-K  9/18/2018
           Investments, LLC.
   10.4      Convertible Promissory Note issued to Triton    Form 8-K  10/22/2018
           Funds LP dated October 12, 2018
             January 2019 Amendment to Promissory Note
  10.5*    dated December 14, 2017, by and between
           BioLargo, Inc. and Vista Capital Investments,
           LLC.
  10.6*      Convertible Promissory Note issued to Vista
           Capital Investments LLC dated January 7, 2019





* Filed hereto.

© Edgar Online, source Glimpses

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on BIOLARGO, INC.
01/11BIOLARGO, INC. : Creation of a Direct Financial Obligation or an Obligation unde..
AQ
2018BIOLARGO : BioLargos subsidiary Clyra Medical secures over $1 million in direct ..
AQ
2018BIOLARGO, INC. : Financial Statements and Exhibits (form 8-K)
AQ
2018BioLargo's subsidiary Clyra Medical secures over $1 million in direct investm..
GL
2018BIOLARGO : Management's Discussion and Analysis of Financial Condition and Resul..
AQ
2018BIOLARGO : s CEO Discusses Business Milestones and FDA Progress with Uptick News..
AQ
2018BIOLARGO : CEO Discusses Business Milestones and FDA Progress with Uptick Newswi..
AQ
2018BIOLARGO : Letter to Stockholders Details Companys Recent Milestones and Success..
AQ
2018BIOLARGO : Letter to Stockholders Details Company's Recent Milestones and Succes..
AQ
2018BIOLARGO, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (fo..
AQ
More news